Results 231 to 240 of about 1,508,326 (290)

Affinity Peptides With pH Sensitivity for the Enrichment of CD38+ Cells

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT The selective enrichment of cell populations based on surface markers is critical for the advancement of gene and cell therapies. Current antibody‐based cell isolation methods, such as fluorescence‐ and magnetic‐activated cell sorting (FACS and MACS), offer high specificity but are limited by scalability, cost, and potential adverse effects on
Gabrielle Rusch   +7 more
wiley   +1 more source

Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report. [PDF]

open access: yesDiabetes Care
Thelin MA   +7 more
europepmc   +1 more source

Acute Lymphoblastic Leukemia Characterized by Rare BCR::FGFR1 Translocation: A Case Report With Literature Review

open access: yesCase Reports in Hematology
Maximilian Al-Bazaz   +8 more
doaj   +1 more source

Low‐Field MRI as a Multiparametric Tool for Large Engineered Tissue Characterization

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Advances in 3D bioprinting have enabled the fabrication of large and complex engineered tissues, but their increasing size demands non‐invasive tools for monitoring structure, maturation, and perfusion. Magnetic Resonance Imaging (MRI) offers unique multiparametric capabilities, yet high‐field systems remain costly and inaccessible for most ...
Yilbert Gimenez   +8 more
wiley   +1 more source

COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34<sup>+</sup> Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis. [PDF]

open access: yesCirculation
Wu J   +20 more
europepmc   +1 more source

Neonatal hypocalcemia and hydrocephalus as early manifestations of intermediate osteopetrosis: successful hematopoietic stem cell transplantation despite negative genetic testing: a case report. [PDF]

open access: yesFront Endocrinol (Lausanne)
Figà L   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy